November 4, 2021
Two pump perspectives
Now that both Tandem and Insulet have reported it’s critical to look beyond the numbers. Not that there was anything wrong with the numbers the numbers for both were just fine and as has become standard operating procedure both companies raised guidance as well. The critical points are these
1. Covid continues to impact sales both domestically and internationally. The good news here is that demand continues to be strong.
2. Thankfully neither company appears to be adversely impacted by the supply chain issues created by covid.
3. Also, good news both have strong . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
